• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

International COVID-19 trial to restart with focus on immune responses.

作者信息

Ledford Heidi

出版信息

Nature. 2021 May 7. doi: 10.1038/d41586-021-01090-z.

DOI:10.1038/d41586-021-01090-z
PMID:33963326
Abstract
摘要

相似文献

1
International COVID-19 trial to restart with focus on immune responses.国际新冠病毒试验将重新启动，重点关注免疫反应。
Nature. 2021 May 7. doi: 10.1038/d41586-021-01090-z.
2
Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2.应对新冠疫情的挑战：对针对严重急性呼吸综合征冠状病毒2的分子机制、免疫反应及治疗方法的见解
Oxf Open Immunol. 2023 Jan 10;4(1):iqad001. doi: 10.1093/oxfimm/iqad001. eCollection 2023.
3
Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination.单细胞分析 SARS-CoV-2 感染和接种疫苗后的适应性免疫反应。
Front Immunol. 2022 Sep 2;13:964976. doi: 10.3389/fimmu.2022.964976. eCollection 2022.
4
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.评估人抗 SARS-CoV-2 恢复期血浆在 COVID-19 重症成人中的疗效和安全性：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.
5
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review.SARS-CoV-2感染中的微小RNA与炎症免疫反应：一篇叙述性综述
Life (Basel). 2022 Feb 15;12(2):288. doi: 10.3390/life12020288.
6
Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.SARS-CoV-2 感染的分子机制与分子治疗。
Curr Mol Med. 2022;22(7):621-639. doi: 10.2174/1566524021666211013121831.
7
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.使用免疫抑制剂的免疫介导炎症性疾病的接种疫苗患者中出现的德尔塔（B.1.617.2）变异株导致的严重急性呼吸综合征冠状病毒2突破性感染：两项前瞻性队列研究的子研究
Lancet Rheumatol. 2022 Jun;4(6):e417-e429. doi: 10.1016/S2665-9913(22)00102-3. Epub 2022 Apr 29.
8
Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis.了解宿主针对新型冠状病毒感染和新冠肺炎发病机制的固有免疫反应。
Immune Netw. 2021 Feb 26;21(1):e1. doi: 10.4110/in.2021.21.e1. eCollection 2021 Feb.
9
Resumption of Intravenous Anti-Cancer Therapy in Breast Cancer: A Real-World Experience During the SARS-CoV-2 Pandemic.乳腺癌患者静脉注射抗癌治疗的恢复：SARS-CoV-2大流行期间的真实世界经验
Cancer Manag Res. 2024 Jan 3;16:1-9. doi: 10.2147/CMAR.S444783. eCollection 2024.
10
Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.SARS-CoV-2 的胃肠道表现：传播、发病机制、免疫调节、微生物失调和临床意义。
Viruses. 2023 May 24;15(6):1231. doi: 10.3390/v15061231.

引用本文的文献

1
Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis.新冠肺炎大流行期间中低收入国家的 COVID-19 卫生产品障碍：快速系统评价和证据综合。
Front Public Health. 2022 Jul 22;10:928065. doi: 10.3389/fpubh.2022.928065. eCollection 2022.
2
Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release.青蒿素抑制中性粒细胞和巨噬细胞趋化、细胞因子产生和 NET 释放。
Sci Rep. 2022 Jun 30;12(1):11078. doi: 10.1038/s41598-022-15214-6.
3
Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
利用自噬作用对抗 SARS-CoV-2：鉴于近期药物研发工作的最新进展。
J Cell Biochem. 2022 Feb;123(2):155-160. doi: 10.1002/jcb.30166. Epub 2021 Oct 20.
4
Clinical research methodology process: what is changing with COVID-19?临床研究方法学流程：新冠肺炎疫情带来了哪些变化？
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E161-E167. doi: 10.1093/eurheartj/suab112. eCollection 2021 Oct.
5
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.急性相蛋白升高会影响 COVID-19 试验中的药代动力学：来自 CounterCOVID-伊马替尼研究的经验教训。
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1497-1511. doi: 10.1002/psp4.12718. Epub 2021 Oct 24.
6
One year on: The impact of COVID-19 on clinical research.一年之后：新冠疫情对临床研究的影响
Eur J Intern Med. 2021 Oct;92:24-27. doi: 10.1016/j.ejim.2021.08.008. Epub 2021 Aug 25.
7
Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?新型冠状病毒肺炎疫苗接种者的抗新型冠状病毒 2 抗体检测：为何、何时以及如何进行？
Diagnostics (Basel). 2021 May 25;11(6):941. doi: 10.3390/diagnostics11060941.